20
Participants
Start Date
May 1, 2021
Primary Completion Date
June 14, 2022
Study Completion Date
December 1, 2024
Fibroblast growth factor 21 infusion
Infusion of Fibroblast growth factor 21
Placebo infusion (saline)
Infusion of Saline
Amalie R Lanng, Hellerup
The Novo Nordisk Foundation Center for Basic Metabolic Research
OTHER
University Hospital, Gentofte, Copenhagen
OTHER